Poster Presentations
POSTER EXHIBITION: Wednesday, October 30, 2024 between 13:00 and 19:00 in a room G403

(AB. 2) Late multiple extra-thoracic metastasis from thymoma biopsy seeding, Carlos Pinto, Portugal (A case selected for presentation at TUMOR BOARD)

(AB. 6) Extensive Thymothymectomy with Lung-Sparing Decortication Pleurectomy and Intraoperative Photodynamic Therapy for Stage IV Thymoma, Yei-San Hsieh, Taiwan

(AB. 8) A case of mediastinal germ cell tumor with vasculogenic mesenchymal tumor components sharing a PTEN mutation with acute megakaryoblastic leukemia, Yu Naito, Japan

(AB. 9) Lenvatinib: A retrospective multicenter study of its real-world efficacy and safety in unresectable or recurrent thymic carcinoma, Satoshi Miyamoto, Japan

(AB. 10) Resection of an Epithelioid Hemangioendothelioma Arising from the Superior Vena Cava: a case report, Xiuxiu Hao, China

(AB. 11) Two cases of mediastinal germ cell tumor with somatic-type malignancy with neuroendocrine tumor, Tomoki Nishimura, Japan

(AB. 12) Resected case of mediastinal myxoid liposarcoma, Takayuki Kosaka, Japan

(AB. 13) A case of thymic typical carcinoid successfully resected by robot-assisted thoracoscopic surgery, Akira Ogihara, Japan

(AB. 16) Impact of Neoadjuvant Therapy followed by Surgical Intervention for Thymic Carcinoma Patients, Shota Nakamura, Japan

(AB. 17) Surgical treatment strategy for thymic cancer invading the aorta, Yasushi Shintani, Japan

(AB. 18) Robotic thymectomy is an ideal surgical treatment for Good’s syndrome, Shinya Otsuka, Japan

(AB. 19) Extent of Thymectomy in Anti-Acetylcholine Receptor Antibody-Positive Thymoma, Yasufumi Uematsu, Japan

(AB. 20) Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, Tatsuo Furuya, Japan

(AB. 22) Remarkable Long-term Survival Following Surgical Resection and Chemotherapy in Type A Thymoma with Bilateral Pulmonary Metastasis: A Rare Case Report, Wei Gan, China

(AB. 23) A case of invasive thymoma with rapid response to PAC therapy, after an early postoperative recurrence, Chika Harada, Japan

(AB. 25) Robotic thymectomy for Morvan's syndrome associated with thymoma: a case report, Daichi Kakibuchi, Japan

(AB. 30) Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study, Lei Jin, China

(AB. 31) Superior mediastinal tumor, distribution of the diseases and its clinical course, Takao Nakanishi, Japan

(AB. 32) Prognostic impact of serum CYFRA 21-1 levels on postoperative outcomes of thymic epithelial tumors, Haruhiko Shiiya, Japan

(AB. 33) TGF-β1 as an active biomarker along with PD-L1 expression for the malignant potential in thymic epithelial tumors, Chiaki Nakazono, Japan

(AB. 34) Remission of recurrent pleural thymoma achieved with Lenvatinib as a single agent, Yi Chen Chang, Taiwan

(AB. 35) Tumor size as an independent prognosticator in advanced thymic epithelial tumors requiring a combined resection of adjacent organs and dissemination, Satoru Okada, Japan

(AB. 36) The new TNM classification and Masaoka staging system prognosis of thymoma: a retrospective single-center study, Takao Shigenobu, Japan

(AB. 38) Evaluation of surgical treatment of myasthenia gravis complicated thymoma, Naoko Ose, Japan

(AB. 41) The Impact of Postoperative Radiotherapy for Thymoma without Other Malignancies: Propensity-Matched Analysis of SEER database, Zhentao Yu, China

(AB. 42) Impact of Lymph Node Dissection on Thymoma: Propensity Score Matched Analysis of SEER Database, Zhentao Yu, China

(AB. 43) Primary posterior mediastinal benign leiomyoma arising from accessory hemiazygos vein, Naoto Kitahara, Japan

(AB. 44) Diaphragmatic Plication in Surgery for Complex Mediastinal Tumor, Ye Yuan, China

(AB. 45) Assessment of apoptotic priming in thymic epithelial tumors to define hallmarks of pathogenesis and novel therapeutic strategies, Christopher Nabel, USA

(AB. 46) Paraplegia as a first clinical presentation of Giant Cell Tumor of the Thoracic Spine Presenting as a Posterior Mediastinal Tumor with Cutaneous TBC, Sukarti Sukarti, Indonesia

(AB. 47) Histopathologic and Clinical Features of Mediastinal Germ Cell Tumors – Preliminary Results of An International, Multi-Institutional Study, Anja Roden, USA

(AB. 48) Insights into Hemi-Clamshell Incision for Mediastinal Tumor Resection, Chengyuan Fang, USA

(AB. 50) Spatial transcriptomics to dissect the cellular heterogeneity in thymic carcinoma, Minoru Matsumoto, Japan

(AB. 52) Short-term outcomes of uniportal subxiphoid thoracoscopic thymectomy for thymic tumors, Wang Shuai, China

(AB. 53) Metabolic profiles and clinical outcome in patients with thymic epithelial tumors, Erica Pietroluongo, Italy

(AB. 54) Clinical Outcome And Serum Cytokonome Profile In Patients With Thymic Epithelial Tumors, Erica Pietroluongo, Italy

(AB. 55) Clinical Outcome And Immunophenotype In Patients With Thymic Epithelial Tumors, Erica Pietroluongo, Italy

(AB. 57) Impact of tumor-infiltrating lymphocytes, tertiary lymphoid structures, and blood inflammatory markers in thymic cancer patients undergoing surgery, Tomohiro Habu, Japan

(AB. 58) Single-cell RNA-seq reveals altered gene expression and cellular composition in thymic epithelial cells of type B Thymoma, Nobuko Akiyama, Japan

(AB. 60) The Contribution of H.K. Müller-Hermelink to the Understanding of Human Thymic Pathology, Mirella Marino, Italy 

(AB. 61) AI-powered Differentiation of Thymomas (A and B3) and Thymic Carcinoma Using Histopathological Analysis of H&E Whole Slide Images, Jan von der Thüsen, The Netherlands

(AB. 62) Thymomatous myasthenia gravis is associated with fluctuations in CD4-positive T-cell subsets through the activity of the PI3K-Akt-mTOR pathway, Shunta Ishihara, Japan

(AB. 63) Complex Management of Thymic Epithelial Tumors Associated with Immuno-Haematological Disorders at the Diagnosis, Giovannella Palmieri, Italy

(AB. 64) Thymic Epithelial Tumors and Haematological Malignancies: a monocentric experience, Giovannella Palmieri, Italy

(AB. 66) Deep dive into the NEJM study suggesting health consequences after thymectomy, Frank Detterbeck, USA

(AB. 68) One case of recurrence of atypical A thymoma subsequent to undergoing surgery for type AB thymoma, Yu-cheng Wei, China

(AB. 70) Impact of relative dose intensity of platinum-base chemotherapy as first line treatment in patients with Thymic Epithelial Tumors, Erica Pietroluongo, Italy

(AB. 71) Clinical landscape and immunological features of patients with thymic carcinoma, Erica Pietroluongo, Italy

(AB. 72) Comparison of outcomes of minimally invasive surgery versus sternotomy for early-stage thymic epithelial tumors: a single-center retrospective analysis, Hiromitsu Takizawa, Japan

(AB. 73) The feasibility and efficacy of surgery followed by induction therapy for advanced thymic carcinoma, Yuriko Terada, Japan

(AB. 74) Sequential induction chemoradiotherapy for locally advanced thymic tumors: A phase II clinical trial, Xuefei Zhang, China

(AB. 78) Phase II, neo-adjuvant pembrolizumab, paclitaxel, carboplatin therapy followed by post operational pembrolizumab consolidation in locally advanced thy, Sehhon Park, Republic of Korea

(AB. 79) Rare tumors biobanking and artificial intelligence (AI): complexity and synergism, Mirella Marino, Italy

(AB. 80) Assessing the Predictive Significance of Tumor Size in Thymoma and Thymic Carcinoma: An Analysis Utilizing SEER Database with Propensity Matching, Wei Liu, China

(AB. 83) A case report of thymoma resection with invasion into the superior vena cava, Yuwen Bai, China

(AB. 84) Tumor-T Cell Interactions in Thymic Epithelial Tumors, Laercio DaSilva, USA

(AB. 85) Immunohistochemical markers of thymic origin in a series of 151 primary lung adenocarcinomas, Lara Chalabreysse, France

(AB. 86) Spatial Analysis of T-Cell Development in Type B2 Thymoma Tumour Microenvironment at Single-Cell Resolution, Kirolous Hanna, UK

(AB. 87) The Practice, Intent, and Outcome of Radiotherapy in Thymic Epithelial Tumors – Results from a National Cohort, Ditte M. Moncada, Denmark

(AB. 89) Rebound thymic hyperplasia and immune related adverse events: reality or fantasy, Margaret Ottaviano, Italy

(AB. 90) The antero-superior mediastinum as unique metastatic site of primary unknown desmoplastic melanoma, Margaret Ottaviano, Italy

(AB. 92) Multiplex Immunofluorescence Analysis of Potential Targets in Thymic Epithelial Tumors, Vanya Aggarwal, USA